-
Awarded06/08/2026
-
Today16/09/2026
Utilities
- indicates text translated automatically in your browsing language
Successive supply of medicines to the Maria Skłodowska-Curie National Oncology Institute – National Research Institute, Gliwice Branch
Note: Not all information for this procedure were successfully computed. Please consult linked documents for more details.
1. Successive supplies of the medicinal product Belantamab to the Maria Skłodowska-Curie National Oncology Institute - National Research Institute of the Gliwice Branch 2. The contract is divided into lots: 1) Aethanol 2) Albumin B 3) Chemotherapy 8 4) Peginterferon 5) Tisagenlecleucel 3. Order mode: Direct order Legal basis: Article 214(b) 1 point 6) of the PZP Act. 4. Planned implementation date: successively for a period of 24 months from the date of conclusion of the contract or until the Customer's financial limit for the performance of the contract specified in § 3 sec. 1 of the Agreement. The contract expires when the nominal amount of the contract has been exhausted or the period for which it was concluded has ended, whichever is the earlier. 5. The Contracting Authority invited the Contractor to negotiate: 1) Task no. 1 -FIRMA SENIOR WOJCIECH CIURAJ SENIOR ul. Piaskowa, No. 47, 44-350 Gorzyce wojtekciuraj@gmail.com 2) task No. 2- Csl Behring Sp. z o.o. ul. BRANICKI, no. 17 02-972 WARSAW, jacek.kulis@cslbehring.com 3) task no. 3 - Fresenius Medical Care Polska - S.A. ul. KRZYWA, nr 13, 60-118 Poznań malgorzata.synowiec@freseniusmedicalcare.com, pl@freseniusmedicalcare.com 4) task no 4 - NEUCA S.A., ul. Forteczna 35-37, 87-100 Toruń, tenderi.szpitale@neuca.pl 5) "NOVARTIS POLAND" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ ul. MARYNARSKA, nr 15, 02-674 Warsaw, jaroslaw.nieradko@novartis.com
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.